Open access
Open access
Powered by Google Translator Translator

RCT | Safety and efficacy of Liraglutide vs. Colesevelam for treating bile acid diarrhea.

26 Jul, 2022 | 12:29h | UTC

Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)

Commentary: Diabetes Drug for Bile Acid Diarrhea Bests Standard of Care in Small Trial — Liraglutide proves superior to colesevelam for cutting daily stool frequency in Danish trial – MedPage Today (free registration required)


Commentary on Twitter


Stay Updated in Your Specialty

No spam, just news.